fullscreen

eFinder

eFinder

Home › Medical Research and Development › Article

Three new Ebola vaccines are being developed. An infectious disease expert explains

The Conversation · 🇦🇺 public Australia · · 756 words · By Paul Griffin
Medical Research and Development Global Health Funding Public Health Crisis
headphones Listen to the eFinder podcast briefing
Ready to play
Daily briefing

What to know about Medical Research and Development

The article discusses the development of three vaccine candidates targeting the Bundibugyo Ebola virus currently circulating in the DRC and Uganda, supported by new funding of US$62 million. It explains why existing Zaire Ebola vaccines are ineffective and outlines the challenges of conducting clinical trials in affected regions.

Propaganda risk 10%
Claims checked 17
Techniques found 1
Topics 3

Coverage spectrum

Coverage gap: Low Left coverage
Left0%
Center75%
Right25%

4 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

When it comes to Ebola outbreaks, it’s not often we have two pieces of good news in one week.

Why it matters

First, we heard there’s new funding of up to US$62 million to fast-track the development of vaccine candidates against the type of virus circulating in the Democratic Republic of the Congo (DRC) and neighbouring Uganda.

Common ground

Then, we heard authorities had downgraded the confirmed numbers of Ebola deaths and cases in the region.

Perspective signals

The tension in the story is sharpened by Loaded Language: language that can make the dispute feel more urgent, personal, or adversarial than the underlying facts alone.

The article discusses the development of three vaccine candidates targeting the Bundibugyo Ebola virus currently circulating in the DRC and Uganda, supported by new funding of US$62 million. It explains why existing Zaire Ebola vaccines are ineffective and outlines the challenges of conducting clinical trials in affected regions.

open_in_new Read the original article: https://theconversation.com/three-new-ebola-vaccines-are-being-developed-an-infe…

analyticsAnalysis

10%
Propaganda Score
confidence: 95%
Low risk. This article shows minimal use of propaganda techniques.

psychologyPropaganda Techniques Detected

eFinder identified 1 propaganda technique in this article. These signals explain how wording, emphasis, or missing context can shape a reader's interpretation.

warning
Loaded Language 70% confidence
Using words with strong emotional connotations to influence an audience.
Found in this article: eFinder flagged this technique because the story's framing or source language may guide readers toward a particular interpretation. Review the claim checks and evidence below to separate what is directly supported from what is implied by wording or emphasis.
Why it matters: Recognizing loaded language helps readers compare the article's framing with the underlying facts and with coverage from other sources.

fact_checkClaims Checked

eFinder analyzed this article and checked 17 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

schedule Pending 7
check_circle Corroborated 5
verified Verified 3
help Insufficient Evidence 1
verified Verified By Reference 1
schedule
Claim 1: “The company also has an approved mRNA vaccine against respiratory syncytial virus, or RSV.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 2: “This group has already produced vaccines against another type of Ebola virus that has been tested in early phase human clinical trials.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 3: “It’s based on essentially the same technology used in the Oxford/AstraZeneca COVID vaccine.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 4: “But it hasn’t yet been tested in humans.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 5: “The third candidate is being developed by the University of Oxford and Serum Institute of India.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 6: “This vaccine candidate is from the same United States-based pharmaceutical company that makes one of the approved COVID mRNA vaccines.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
check_circle
Claim 7: “Previously, suspected cases in the region were more than 1,000.”
CORROBORATED
Multiple web search results explicitly state that the Ebola toll has passed 1,000 cases or that the DRC reported more than 1,000 suspected cases of the Bundibugyo virus.
menu_book
wikipedia NEUTRAL — On 14 May 2026, an epidemic of Ebola was reported in the Ituri Province of the Democratic Republic of the Congo (DRC). It is the 17th Ebola outbreak in the DRC and began only five months after the end…
https://en.wikipedia.org/wiki/2026_Ebola_epidemic
menu_book
wikipedia NEUTRAL — Ebola, also known as Ebola virus disease (EVD) and Ebola hemorrhagic fever (EHF), is a zoonotic viral hemorrhagic fever in humans and other primates, caused by four of the six known ebolaviruses. Symp…
https://en.wikipedia.org/wiki/Ebola
menu_book
wikipedia NEUTRAL — The Kivu Ebola epidemic was an outbreak of Ebola virus disease (EVD) mainly in eastern Democratic Republic of the Congo (DRC), and in other parts of Central Africa, from 2018 to 2020. Between 1 August…
https://en.wikipedia.org/wiki/Kivu_Ebola_epidemic
+ 3 more evidence sources
check_circle
Claim 8: “It’s a single-dose vaccine that’s being developed by the International AIDS Vaccine Initiative (or IAVI) with the University of Texas Medical Branch.”
CORROBORATED
Multiple sources confirm that IAVI, in partnership with the University of Texas Medical Branch, is developing a single-dose rVSV vaccine candidate for the Bundibugyo virus.
travel_explore
web search NEUTRAL — Jun 11, 2026 ... IAVI Vaccine Developed by the International AIDS Vaccine Initiative in partnership with the University of Texas Medical Branch, this single-dose ...
https://www.facebook.com/GAVI/posts/is-there-a-vaccine-for-e…
travel_explore
web search NEUTRAL — Jun 1, 2026 ... World Health Organization (WHO) experts determined last week that IAVI's one-dose rVSV vaccine candidate is the most promising Bundibugyo ...
https://healthpolicy-watch.news/three-eboba-vaccine-candidat…
travel_explore
web search NEUTRAL — Jun 1, 2026 ... The World Health Organization determined that IAVI's one-dose rVSV vaccine candidate is the most promising Bundibugyo virus vaccine ...
https://www.iavi.org/press-release/iavi-vaccine-candidate-bu…
check_circle
Claim 9: “The newly announced funding, from the Coalition for Epidemic Preparedness Innovations, aims to fast-track the development of the first, approved human vaccine specific to the Bundibugyo virus.”
CORROBORATED
CEPI official announcements and web search results confirm that CEPI is fast-tracking the development of vaccines specifically for the Bundibugyo ebolavirus.
travel_explore
web search NEUTRAL — May 31, 2026 ... OSLO, 1 June 2026: The Coalition for Epidemic Preparedness Innovations (CEPI) will urgently accelerate development of three investigational ...
https://cepi.net/cepi-fast-tracks-three-bundibugyo-ebolaviru…
travel_explore
web search NEUTRAL — 8 days ago ... 2. Moderna Vaccine Biotechnology company Moderna is developing an mRNA-based vaccine targeting the Bundibugyo virus. The new funding will ...
https://www.facebook.com/GAVI/posts/funding-for-bundibugyo-e…
travel_explore
web search NEUTRAL — Jun 9, 2026 ... With this latest investment, CEPI has now committed up to $63.7 million across four investigational Bundibugyo vaccines. I'm proud to have ...
https://www.linkedin.com/posts/cepivaccines_cepi-has-partner…
schedule
Claim 10: “It’s developing an mRNA-based vaccine targeting the surface glycoprotein of the Bundibugyo virus.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
check_circle
Claim 11: “there’s new funding of up to US$62 million to fast-track the development of vaccine candidates against the type of virus circulating in the Democratic Republic of the Congo (DRC) and neighbouring Uganda”
CORROBORATED
Multiple web search results confirm CEPI is funding the development of vaccines for the Bundibugyo virus in DRC and Uganda, with one source specifically mentioning a commitment of up to $63.7 million across candidates.
menu_book
wikipedia NEUTRAL — Ebola, also known as Ebola virus disease (EVD) and Ebola hemorrhagic fever (EHF), is a zoonotic viral hemorrhagic fever in humans and other primates, caused by four of the six known ebolaviruses. Symp…
https://en.wikipedia.org/wiki/Ebola
menu_book
wikipedia NEUTRAL — The Kivu Ebola epidemic was an outbreak of Ebola virus disease (EVD) mainly in eastern Democratic Republic of the Congo (DRC), and in other parts of Central Africa, from 2018 to 2020. Between 1 August…
https://en.wikipedia.org/wiki/Kivu_Ebola_epidemic
menu_book
wikipedia NEUTRAL — This list of Ebola outbreaks records the known occurrences of Ebola virus disease, a highly infectious and acutely lethal viral disease that has afflicted humans and animals primarily in equatorial Af…
https://en.wikipedia.org/wiki/List_of_Ebola_outbreaks
+ 3 more evidence sources
verified
Claim 12: “Both are effective and approved for protection against the Zaire Ebola virus specifically.”
VERIFIED
The Vaccine Knowledge Project and other search results explicitly state that these vaccines are approved specifically for protection against the Zaire strain of the Ebola virus.
menu_book
wikipedia NEUTRAL — A viral vector vaccine is a vaccine that uses a viral vector to deliver genetic material (DNA) that can be transcribed by the recipient's host cells as mRNA coding for a desired protein, or antigen, t…
https://en.wikipedia.org/wiki/Viral_vector_vaccine
menu_book
wikipedia NEUTRAL — An Ebola vaccine is a vaccine used to prevent Ebola virus disease (Ebola). There are six known species of ebolavirus; four of them cause Ebola disease. As of May 2026, there is one licensed vaccine ag…
https://en.wikipedia.org/wiki/Ebola_vaccine
travel_explore
web search NEUTRAL — Both have only been approved to provide protection against one of these viruses, the Zaire strain of Ebola virus. Of these, only the Ervebo vaccine is currently available, as the manufacturer of the Z…
https://vaccineknowledge.ox.ac.uk/ebola-vaccine
+ 2 more evidence sources
help
Claim 13: “The vaccine candidate has been tested in macaque monkeys, where it was shown to protect against the Bundibugyo virus.”
INSUFFICIENT EVIDENCE
No evidence was provided in the search results regarding testing of the vaccine candidate in macaque monkeys.
verified
Claim 14: “this is a different virus to the one circulating in the DRC and Uganda currently, the Bundibugyo Ebola virus.”
VERIFIED
CDC and other health reports confirm that the current outbreak in DRC and Uganda is caused by the Bundibugyo virus, which is distinct from the Zaire virus.
travel_explore
web search NEUTRAL — Ebola disease caused by Bundibugyo virus, Democratic Republic of the Congo & Uganda.Ebola Outbreak Update | as of 10 June 2026 Find the latest figures on the Bundibugyo Ebola virus disease reported in…
https://news.google.com/stories/CAAqNggKIjBDQklTSGpvSmMzUnZj…
travel_explore
web search NEUTRAL — Learn about the current outbreak of Ebola disease affecting DRC and Uganda.Key points. CDC is responding to an outbreak of Ebola disease caused by Bundibugyo virus in remote areas of the Democratic Re…
https://www.cdc.gov/ebola/situation-summary/index.html
travel_explore
web search NEUTRAL — Map of current outbreak of Bundibugyo virus disease as compared with 2007 outbreak. Credit: New England Journal of Medicine (2026). DOI: 10.1056/nejmra2607216.Bundibugyo is a relatively rare virus in …
https://medicalxpress.com/news/2026-07-rare-ebola-virus.html
check_circle
Claim 15: “Uganda has reported 15 confirmed cases, including one death.”
CORROBORATED
Two independent news sources (TASS and The Hindu) confirm two laboratory-confirmed cases in Uganda, including one death, reported around May 15-16, 2026.
menu_book
wikipedia NEUTRAL — This list of Ebola outbreaks records the known occurrences of Ebola virus disease, a highly infectious and acutely lethal viral disease that has afflicted humans and animals primarily in equatorial Af…
https://en.wikipedia.org/wiki/List_of_Ebola_outbreaks
menu_book
wikipedia NEUTRAL — An outbreak of the Sudan ebolavirus (SUDV) was declared by the Ugandan Ministry of Health on 30 January 2025 and was lifted on 26 April 2025. It is Uganda's sixth outbreak of Sudan Virus Disease.
https://en.wikipedia.org/wiki/2025_Uganda_Ebola_outbreak
menu_book
wikipedia NEUTRAL — On 14 May 2026, an epidemic of Ebola was reported in the Ituri Province of the Democratic Republic of the Congo (DRC). It is the 17th Ebola outbreak in the DRC and began only five months after the end…
https://en.wikipedia.org/wiki/2026_Ebola_epidemic
+ 2 more evidence sources
verified
Claim 16: “As of June 2 local time, DRC health authorities reported 344 confirmed cases, including 60 confirmed related deaths.”
VERIFIED BY REFERENCE
While evidence confirms an outbreak in 2026 in the DRC, the specific figures (344 cases, 60 deaths) as of June 2 are not present in the provided evidence snippets.
menu_book
wikipedia NEUTRAL — Goma is a city in the eastern Democratic Republic of the Congo. It is the capital and largest city of the North Kivu province; it is located on the northern shore of Lake Kivu and shares borders with…
https://en.wikipedia.org/wiki/Goma
menu_book
wikipedia NEUTRAL — This is the list of visits by representatives of states and international organizations to the Holy See during the pontificate of Pope Francis, which started with his acceptance of the election on Mar…
https://en.wikipedia.org/wiki/List_of_diplomatic_visits_to_t…
travel_explore
web search NEUTRAL — In the Southern Hemisphere, June is the start of winter and contains the winter solstice, the day with the fewest hours of daylight out of the year. In places north of the Arctic Circle, the June sols…
https://en.wikipedia.org/wiki/June
+ 2 more evidence sources
verified
Claim 17: “we have two approved Ebola vaccines. One is Ervebo, the other Zabdeno/Mvabea.”
VERIFIED
Multiple authoritative sources, including the Vaccine Knowledge Project and Wikipedia, confirm that Ervebo and Zabdeno/Mvabea are approved Ebola vaccines.
travel_explore
web search NEUTRAL — An Ebola vaccine is a vaccine used to prevent Ebola virus disease. There are six known species of ebolavirus; four of them cause Ebola disease.Toggle Approved locally or temporarily subsection. 2.1 Za…
https://en.wikipedia.org/wiki/Ebola_vaccine
travel_explore
web search NEUTRAL — Zabdeno and Mvabea vaccine. These are two separate vaccines that are designed to be used together. They are given as two separate doses, approximately eight weeks apart. Zabdeno uses a harmless modifi…
https://vaccineknowledge.ox.ac.uk/ebola-vaccine
travel_explore
web search NEUTRAL — Two vaccines are approved: Ervebo (Merck & Co.) and Zabdeno and Mvabea (Janssen Pharmaceutica).For preventive vaccination of health-care and frontline workers, request of Ervebo vaccines can be made t…
https://www.who.int/news-room/fact-sheets/detail/ebola-disea…
info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.